Headwinds For C.R. Bard, According To Barclays

By: via Benzinga
Shares of C.R. Bard (NYSE: BCR) are down following a report from Barclays regarding test results and the Medtronic (NYSE: MDT) and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.